SCHEMBL30710179

SCHEMBL30710179

[2H]OS(=O)(=O)C1C=CC=CC1(C)c1cccc(Cl)c1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 8/20 0.35
CHRNA1 P02708 7/20 0.35
CHRNB1 P11230 7/20 0.35
CHRNB2 P17787 7/20 0.35
SLC6A2 P23975 7/20 0.35
CHRNB4 P30926 7/20 0.35
CHRNA3 P32297 7/20 0.35
CHRNA4 P43681 7/20 0.35
SLC6A4 P31645 7/20 0.35
CHRNG P07510 5/20 0.35
CHRND Q07001 5/20 0.35
HSD11B1 P28845 1/20 0.34
HCAR3 P49019 1/20 0.34
HCAR2 Q8TDS4 1/20 0.34
CCR2 P41597 1/20 0.33
HPGD P15428 1/20 0.30
CCR1 P32246 1/20 0.30
TP53 P04637 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30125098 0.93 SLC6A3 (0.37) SLC6A3CHRNA1CHRNB1CHRNB2SLC6A2
SCHEMBL30124758 0.80 CCR2 (0.35) SLC6A3CHRNA1CHRNB1CHRNB2SLC6A2
SCHEMBL30124641 0.79 CCR2 (0.36) SLC6A3CHRNA1CHRNB1CHRNB2SLC6A2
SCHEMBL30710190 0.78 CHRNA1 (0.31) SLC6A3CHRNA1CHRNB1CHRNB2SLC6A2
SCHEMBL29987487 0.78 TSHR (0.31) SMN1; SMN2
SCHEMBL30710180 0.74 KMT2A (0.36) SLC6A3SLC6A2SLC6A4
SCHEMBL30124933 0.71 HSD11B1 (0.31) HSD11B1CCR2
SCHEMBL30124886 0.70 PTPN1 (0.33) CHRNA1CHRNB1CHRNB2SLC6A2CHRNB4
SCHEMBL30710205 0.70 CRHBP (0.38)
SCHEMBL30124913 0.68 CA12 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115403494-B Method for synthesizing beta-hydroxy sulfone derivative by oxygen-initiated olefin double-functionalization under mild condition 湘潭大学 2024-01-02 CN disclosed